Drug Discovery & Development

Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. We report on innovative drug introductions and promising pipeline candidates from Big Pharma and smaller players, as well as relevant clinical trial trends. WIth the growing interest in artificial intelligence and machine learning in drug discovery and development, we provide insights into the latest AI-driven methodologies, platforms, and tools being harnessed by the industry, showcasing real-world applications and case studies that highlight the tangible benefits and challenges of integrating these technologies.

The publication also covers promising technological developments relevant to the biotech, biopharma and pharma industries, including advances in artificial intelligence, genomic/proteomic sequencing and microscopy. Other areas of focus include orphan drugs, drug advances for oncology, neurological disease and infectious disease including vaccines and other therapies for infectious disease.

In the AI domain, our aim is to create a nexus where pharma professionals, data scientists, AI experts, and other stakeholders can gain a holistic understanding of the evolving drug discovery landscape, enriched by the capabilities of artificial intelligence and machine learning.